UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

Phase 2

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Normal Saline
Drug: Gallium nitrate

First Posted Date: 2015-02-03

Last Posted Date: 2019-03-21

Lead Sponsor: University of Washington

Target Recruit Count: 119

Registration Number: NCT02354859

Locations: 🇺🇸
Jackson Memorial Hospital; University of Miami Hospital; University of Miami Hospital and Clinics, Miami, Florida, United States
🇺🇸
AL Adult Birmingham / The Children's Hospital Atlanta, Birmingham, Alabama, United States
🇺🇸
Columbus CC and Peds / Nationwide Children's Hospital, Columbus, Ohio, United States

and more 20 locations

Texting to Improve Testing (TextIT):

Not Applicable

Conditions: HIV

Interventions: Other: Text messaging after 6 months of control
Other: Text messaging from beginning

First Posted Date: 2015-01-29

Last Posted Date: 2018-05-08

Lead Sponsor: University of Washington

Target Recruit Count: 2508

Registration Number: NCT02350140

Locations: 🇰🇪
Kenya Medical Research Institute, Family AIDS Care and Education Services, Kisumu, Nyanza, Kenya

Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening

Not Applicable

Completed

Conditions: Pre-induction Cervical Ripening

Interventions: Device: mechanical pre-induction cervical ripening

First Posted Date: 2015-01-26

Last Posted Date: 2015-01-26

Lead Sponsor: University of Washington

Target Recruit Count: 105

Registration Number: NCT02344459

Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer

Not Applicable

Completed

Conditions: Caregiver

Interventions: Other: Psychosocial Support for Caregiver
Other: Questionnaire Administration
Other: Sham Intervention

First Posted Date: 2015-01-16

Last Posted Date: 2016-02-15

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT02339870

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Phase 2

Active, not recruiting

Conditions: Chronic Lymphocytic Leukemia
Follicular Lymphoma
Lymphoplasmacytic Lymphoma
Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Marginal Zone Lymphoma
Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
Waldenstrom Macroglobulinemia

Interventions: Drug: Ixazomib Citrate
Other: Laboratory Biomarker Analysis
Biological: Rituximab

First Posted Date: 2015-01-16

Last Posted Date: 2025-01-08

Lead Sponsor: University of Washington

Target Recruit Count: 33

Registration Number: NCT02339922

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder
Depression
Alcohol-Related Disorders
Suicidal Ideation
Quality of Life
Substance-Related Disorders
Mild Cognitive Impairment

Interventions: Behavioral: Motivational Interviewing
Behavioral: Cognitive Behavioral Therapy Elements
Drug: Psychotropic Drugs
Other: Care Management

First Posted Date: 2015-01-09

Last Posted Date: 2020-09-11

Lead Sponsor: University of Washington

Target Recruit Count: 40

Registration Number: NCT02335125

CNS Uptake of Intranasal Glutathione

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Reduced Glutathione

First Posted Date: 2014-12-24

Last Posted Date: 2015-04-30

Lead Sponsor: University of Washington

Target Recruit Count: 15

Registration Number: NCT02324426

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Ocular Surface Dry Eye Microbiome

Conditions: Dry Eyes

First Posted Date: 2014-12-03

Last Posted Date: 2014-12-03

Lead Sponsor: University of Washington

Target Recruit Count: 80

Registration Number: NCT02306668

Locations: 🇺🇸
UW Medicine Eye Institute, Seattle, Washington, United States

Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting

Phase 3

Conditions: Chronic Pain

Interventions: Drug: Ketamine

First Posted Date: 2014-12-01

Last Posted Date: 2015-05-27

Lead Sponsor: University of Washington

Target Recruit Count: 32

Registration Number: NCT02303847

Locations: 🇺🇸
Pioneer Family Practice, Lacey, Washington, United States

Provider and Peer Support Intervention to Improve ART Adherence Among Kenyan Men Who Have Sex With Men

Not Applicable

Completed

Conditions: Medication Adherence

Interventions: Behavioral: Shikamana Intervention
Behavioral: Standard Care

First Posted Date: 2014-11-26

Last Posted Date: 2017-07-13

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT02301533

Locations: 🇰🇪
Kenya Medical Research Institute Mtwapa Research Clinic, Mtwapa, Kenya

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy